Increased ventricular sialylation in patients with heart failure secondary to ischemic heart disease

Clinical Cardiology

Volumn 20, Issue 5, 1997, Pages 455-458

  Crook, J Robert ^a   Goldman, Jonathan H ^a   Dalziel, Martin ^a   Madden, Brendan ^a   Mckenna, William J ^a  

^a ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

cardiomyopathy; ischemic heart disease; sialic acids

Indexed keywords

SIALIC ACID;

ARTICLE; CARDIOVASCULAR RESPONSE; CHEMOLUMINESCENCE; CONGESTIVE CARDIOMYOPATHY; CORONARY ARTERY DISEASE; GLYCOSYLATION; HEART FAILURE; HEART LEFT VENTRICLE MUSCLE; HUMAN; HUMAN TISSUE; HYPERTRIGLYCERIDEMIA; ISCHEMIC HEART DISEASE; MICROALBUMINURIA; SIALYLATION; VASCULAR ENDOTHELIUM;

EID: 0030942437     PISSN: 01609289     EISSN: None     Source Type: Journal    
DOI: 10.1002/clc.4960200510     Document Type: Article

References (23)

1. Born G, Palinski W: Unusually high concentrations of sialic acids on the surface of vascular endothelia. Br J Exper Pathol 1985;66:543-549
2. Tertov VV, Orekhov AN, Sobenin IA, Morrisett JD, Gotto AJ, Guevara JJ: Carbohydrate composition of protein and lipid components in sialic acid-rich and -poor low density lipoproteins from subjects with and without coronary artery disease. J Lipid Res 1993;34:365-375
3. Turner G: N-glycosylation of serum proteins in disease and its investigation using lectins. Clin Chim Acta 1992;208:149-171
4. Lindberg G, Eklund GA, Gullberg B, Råstam L: Serum sialic acid concentration and cardiovascular mortality. Br Med J 1991;302:143-146
5. Lindberg G, Råstam L, Gullberg B, Eklund GA: Serum sialic acid concentration predicts both coronary heart disease and stroke mortality: Multivariate analysis including 54,385 men and women during 20.5 years follow-up. Int J Epidemiol 1992;21:253-257
6. Crook MA, Treloar A, Haq M, Tutt P: Serum total sialic acid and acute phase proteins in elderly subjects. Eur J Clin Chem Clin Biochem 1994;32:745-747
7. Crook M, Tutt P: Serum sialic concentration in patients with hypertiglyceridaemia showing the Frederickson's IIB phenotype. Clin Sci 1992;83:593-595
8. Crook MA, Earle K, Morocutti A, Yip J, Viberti G, Pickup JC: Serum sialic acid, a risk factor for cardiovascular disease, is increased in IDDM patients with microalbuminuria and clinical proteinuria. Diabetes Care 1994;17:305-310
9. Watts GF, Crook MA, Haq S, Mandalia S: Serum sialic acid as an indicator of change in coronary artery disease. Metabolism 1995;44:147-148
10. Radhakrishnamurthy B, Berenson G, Pargaokar P: Serum-free and protein-bound sugars and cardiovascular complications in diabetes mellitus. Lab Invest 1976;34:159-165
11. Romero R, Lens X, Novoa D: Sialic acid is a predictor of cardiovascular complications in renal transplantation recipients. Nephron 1993;65:489-490
12. Wu A, Sugii S, Herp A: A table of lectin carbohydrate specificities. In Lectins-Biology, Biochemistry Clinical Biochemistry (Eds, BogHansen T, Freed D), p. 723-740. St Louis, Missouri: Sigma Chemical Company, 1988
13. Goodarzi M, Rafiq M, Turner G: An improved multiwell immunoassay using digoxigenin-labelled lectins to study the glycosylation of purified glycoproteins (abstr). Biochem Soc Trans 1995;23(suppl):168S
14. Crook M: The determination of plasma serum sialic acid. Clin Biochem 1993;26:31-38
15. Haq M, Haq S, Tutt P, Crook M: Serum total sialic acid and lipid-associated sialic acid in normal individuals and patients with myocardial infarction, and their relationship to acute phase proteins. Ann Clin Biochem 1993;30:383-386
16. Hrncir Z, Pidrman V, Tichy M, Hamet A: Serum sialic acid in acute myocardial infarction during a dynamic follow-up. Vnitrni Lekarstri 1975;21:436-439
17. Haq M, Tutt P, Crook M: Plasma sialic acid in myocardial infarction (abstr). Biochem Soc Trans 1992;20(suppl):343S
18. Crook M, Haq M, Haq S, Tutt P: Plasma sialic acid and acute-phase proteins in patients with myocardial infarction. Angiology 1994;45:709-715
19. Flynn M: Sialic acid and cardiovascular mortality. Br Med J 1991; 302:533-534
20. Orekhov AN, Tertov VV, Mukhin DN: Desialylated low-density lipoprotein: A naturally occurring modified lipoprotein with atherogenic potency. Atherosclerosis 1991;86:153-161
21. Orekhov AN, Tertov VV, Sobenin IA, Smirnov VN, Via DP, Guevara J Jr, Gotto A Jr, Morrissett, JD: Sialic acid content of human low density lipoproteins affects their interaction with cell receptors and intracellular lipid accumulation. J Lipid Res 992;33:805-817
22. Jaakkola O, Solakivi T, Tertov VV, Orekhov AN, Miettinen TA, Nikkari T: Characteristics of low-density lipoprotein subfractions from patients with coronary artery disease. Coron Art Dis 1993;4:379-385
23. Ruelland A, Gallou G, Legras B, Paillard F, Cloarec L: LDL sialic acid content in patients with coronary artery disease. Clin Chim Acta 1993;221:127-133